Corona vaccination: study sees high risk from mRNA vaccination – MV Reisinger expert contradicts

A new study on the side effects of mRNA vaccinations is currently causing a stir. Specifically, the risk of serious side effects from vaccination should outweigh the reduction in the risk of being hospitalized due to a corona infection.

Also read: 95% of the population has antibodies against Corona

Side effect data reanalyzed

Researchers from several American universities participated in the study, including renowned Stanford University, which reanalyzed data from Biontech / Pfizer and Moderna phase III clinical trials. Specifically, the study states:

“In the Moderna study, the excess risk of severe AESIs (15.1 per 10,000 participants) was greater than the reduction in the risk of hospitalization for COVID-19 compared to placebo (6.4 per 10,000 participants).

In the Pfizer study, the excess risk of serious AESIs (10.1 per 10,000) was greater than the reduction in the risk of hospitalization for COVID-19 compared to placebo (2.3 per 10,000 participants). “

Read also: Biontech and Moderna sued vaccine damages for the first time

These findings would raise concerns that mRNA vaccines may carry higher risks than initially thought. The reanalysis also revealed “a 36% higher risk of serious adverse events in vaccinated participants in the Pfizer study.”

Rostock Reisinger infectious disease specialist calls the study “false”

Infectious disease specialist Professor Emil Reisinger, Dean and Scientific Director of the Faculty of Medicine of the University of Rostock, classifies the study as “false”. One of the six authors of the study, Professor Peter Doshi of the University of Maryland School of Pharmacy, is a well-known anti-vaccinationist.

Comparing the side effects of vaccination with the hospitalization rate for Covid-19 disease is “nonsense”. The interpretation of Pfizer data would not be shared by WHO.

“Even based on my experience after thousands of vaccinations have been administered, the official information on the type and frequency of side effects of mRNA vaccines seems plausible and credible to me,” says the infectious disease specialist.

Read also: Little demand for corona vaccines

The researchers criticized the Pfizer study data

Finally, the study authors themselves discuss their findings: a common approach in research. They emphasize that the investigation is preliminary. A correct harm-benefit analysis is required.

Individual participant data, i.e. the age and gender of participants with severe side effects, should be published. Pharmaceutical company Pfizer has not yet allowed access to this data, according to the researchers.

Only these data would allow an exact harm-benefit analysis for people at low risk of serious complications from a coronary infection. It is also possible that several serious side effects have occurred in a patient. This does not emerge from the previously published Pfizer data.

Also read: Severe corona course – are vaccinated people more at risk?

The study points to the withdrawal of several vaccines

Researchers criticize Moderna and Pfizer’s different registration practices and an insufficient observation period of one month after administering the second dose to Pfizer – this may have led to an under-count of serious side effects.

The sentence was also explosive: “The adverse events identified after the market launch led to the withdrawal of several vaccines. “They refer to a rotavirus vaccine that has been withdrawn from the market. It is unclear whether the researchers imply that mRNA vaccines should also be withdrawn from the market.

Leave a Reply

Your email address will not be published. Required fields are marked *